Health Care·Pharmaceuticals·$2.8B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.63 | N/A | +2.94% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.63 | N/A | +2.94% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Overall, management conveyed a positive outlook on earnings performance. However, they did not provide specific guidance for future quarters.
Management expressed satisfaction with the EPS performance despite not providing revenue figures.
They emphasized a focus on strategic initiatives to drive future growth.
Prestige Consumer HE's earnings report shows a positive surprise in EPS, which contributed to a slight increase in stock price. The lack of revenue data leaves some uncertainty, but management's comments suggest they are focused on growth strategies. Investors may view the EPS beat as a sign of resilience in the company's performance.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
MONOLITHIC PWR SYS I
Oct 31, 2016